{"id":301730,"date":"2026-10-12T12:00:15","date_gmt":"2026-10-12T06:30:15","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=301730"},"modified":"2026-10-12T12:00:15","modified_gmt":"2026-10-12T06:30:15","slug":"formulation-and-enzyme-maker-stocks-long-term-growth-picks","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/formulation-and-enzyme-maker-stocks-long-term-growth-picks\/","title":{"rendered":"3 Formulation and Enzyme Maker Stocks With a Strong Future Roadmap: Alkem Laboratories, Lincoln Pharmaceuticals and Advanced Enzyme Technologies"},"content":{"rendered":"

Alkem Rs 5,279.00, P\/E 28.43. Lincoln Pharma Rs 558.30, P\/E 11.64. Advanced Enzyme Rs 267.15, P\/E 17.28. Closing prices of 9 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Formulation and enzyme maker stocks with the clearest long-term roadmaps today include Alkem in branded generics franchise, Lincoln Pharma in export formulation range and Advanced Enzyme in enzymes and probiotics range. FY26 revenue growth was 13.7% at Alkem, 9.1% at Lincoln Pharma and 16.5% at Advanced Enzyme. P\/E stands at 28.43 for Alkem (industry 37.59), 11.64 for Lincoln Pharma (industry 37.59) and 17.28 for Advanced Enzyme (industry 37.59). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.<\/p>\n<\/p><\/div>\n

Formulation and enzyme maker stocks give investors exposure to medicines, export formulations and enzymes for health and food. Product launches, export orders and margins decide how much of that demand turns into profit.<\/p>\n

This list covers three formulation and enzyme maker stocks: Alkem Laboratories for branded generics franchise, Lincoln Pharmaceuticals for export formulation range and Advanced Enzyme Technologies for enzymes and probiotics range. Every figure comes from the latest reported financials and the 9 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n